Page last updated: 2024-08-16

sarpogrelate and pitavastatin

sarpogrelate has been researched along with pitavastatin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ito, T; Nomura, S; Okuda, Y; Omoto, S; Shouzu, A; Suzuki, M; Taniura, T	1

Trials

1 trial(s) available for sarpogrelate and pitavastatin

Article	Year
Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study). Vascular health and risk management, 2018, Volume: 14 Topics: Adiponectin; Aged; Aged, 80 and over; Ankle Brachial Index; Arteriosclerosis Obliterans; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Linear Models; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Quinolines; Risk Factors; Succinates; Time Factors; Treatment Outcome	2018

Article

Year

Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study).

Vascular health and risk management, 2018, Volume: 14

Topics: Adiponectin; Aged; Aged, 80 and over; Ankle Brachial Index; Arteriosclerosis Obliterans; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Linear Models; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Quinolines; Risk Factors; Succinates; Time Factors; Treatment Outcome

2018